Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Polypill Products Market


4. Market Overview

4.1. Introduction

4.1.1. Application/Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Polypill Products Market Analysis and Forecast, 2017–2027


5. Market Outlook

5.1. Epidemiology of Cardiovascular Diseases, Diabetes Mellitus and Infectious Diseases

5.2. Pipeline Analysis

5.3. Regulatory Scenario/Drug Approval Process, by Country/Sub-region

5.4. Technological Advancements


6. Global Polypill Products Market Analysis and Forecast, by Application

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Polypill Products Market Value Forecast, by Application, 2017–2027

6.3.1. Cardiovascular

6.3.2. Diabetes Mellitus

6.3.3. Anti-infective

6.3.4. Others

6.4. Global Polypill Products Market Attractiveness Analysis, by Application


7. Global Polypill Products Market Analysis and Forecast, by Distribution Channel

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Polypill Products Market Value Forecast, by Distribution Channel, 2017–2027

7.3.1. Hospital Pharmacies

7.3.2. Retail Pharmacies

7.3.3. Online Pharmacies

7.4. Global Polypill Products Market Attractiveness Analysis, by Distribution Channel


8. Global Polypill Products Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Global Polypill Products Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Global Polypill Products Market Attractiveness Analysis, by Region


9. North America Polypill Products Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.2. North America Polypill Products Market Value Forecast, by Application, 2017–2027

9.2.1. Cardiovascular

9.2.2. Diabetes Mellitus

9.2.3. Anti-infective

9.2.4. Others

9.3. North America Polypill Products Market Value Forecast, by Distribution Channel, 2017–2027

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Online Pharmacies

9.4. North America Polypill Products Market Value Forecast, by Country, 2017–2027

9.4.1. U.S.

9.4.2. Canada

9.5. North America Polypill Products Market Attractiveness Analysis

9.5.1. By Application

9.5.2. By Distribution Channel

9.5.3. By Country


10. Europe Polypill Products Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. Europe Polypill Products Market Value Forecast, by Application, 2017–2027

10.2.1. Cardiovascular

10.2.2. Diabetes Mellitus

10.2.3. Anti-infective

10.2.4. Others

10.3. Europe Polypill Products Market Value Forecast, by Distribution Channel, 2017–2027

10.3.1. Hospital Pharmacies

10.3.2. Retail Pharmacies

10.3.3. Online Pharmacies

10.4. Europe Polypill Products Market Value Forecast, by Country/Sub-region, 2017–2027

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Europe Polypill Products Market Attractiveness Analysis

10.5.1. By Application

10.5.2. By Distribution Channel

10.5.3. By Country/Sub-region


11. Asia Pacific Polypill Products Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Asia Pacific Polypill Products Market Value Forecast, by Application, 2017–2027

11.2.1. Cardiovascular

11.2.2. Diabetes Mellitus

11.2.3. Anti-infective

11.2.4. Others

11.3. Asia Pacific Polypill Products Market Value Forecast, by Distribution Channel, 2017–2027

11.3.1. Hospital Pharmacies

11.3.2. Retail Pharmacies

11.3.3. Online Pharmacies

11.4. Asia Pacific Polypill Products Market Value Forecast, by Country/Sub-region, 2017–2027

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Asia Pacific Polypill Products Market Attractiveness Analysis

11.5.1. By Application

11.5.2. By Distribution Channel

11.5.3. By Country/Sub-region


12. Latin America Polypill Products Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Latin America Polypill Products Market Value Forecast, by Application, 2017–2027

12.2.1. Cardiovascular

12.2.2. Diabetes Mellitus

12.2.3. Anti-infective

12.2.4. Others

12.3. Latin America Polypill Products Market Value Forecast, by Distribution Channel, 2017–2027

12.3.1. Hospital Pharmacies

12.3.2. Retail Pharmacies

12.3.3. Online Pharmacies

12.4. Latin America Polypill Products Market Value Forecast, by Country/Sub-region, 2017–2027

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Latin America Polypill Products Market Attractiveness Analysis

12.5.1. By Application

12.5.2. By Distribution Channel

12.5.3. By Country/Sub-region

13. Middle East & Africa Polypill Products Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Middle East & Africa Polypill Products Market Value Forecast, by Application, 2017–2027

13.2.1. Cardiovascular

13.2.2. Diabetes Mellitus

13.2.3. Anti-infective

13.2.4. Others

13.3. Middle East & Africa Polypill Products Market Value Forecast, by Distribution Channel, 2017–2027

13.3.1. Hospital Pharmacies

13.3.2. Retail Pharmacies

13.3.3. Online Pharmacies

13.4. Middle East & Africa Polypill Products Market Value Forecast, by Country/Sub-region, 2017–2027

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Middle East & Africa Polypill Products Market Attractiveness Analysis

13.5.1. By Application

13.5.2. By Distribution Channel

13.5.3. By Country/Sub-region

14. Competitive Landscape

14.1. Market Player - Competition Matrix (By Tier and Size of companies)

14.2. Market Share Analysis/Ranking, by Company, 2018

14.3. Company Profiles

14.3.1. Pfizer Inc.

14.3.1.1. Company Overview

14.3.1.2. Company Financials

14.3.1.3. Growth Strategies

14.3.1.4. SWOT Analysis

14.3.2. AstraZeneca

14.3.2.1. Company Overview

14.3.2.2. Company Financials

14.3.2.3. Growth Strategies

14.3.2.4. SWOT Analysis

14.3.3. Merck & Co., Inc. (Merck Sharp & Dohme Corp)

14.3.3.1. Company Overview

14.3.3.2. Company Financials

14.3.3.3. Growth Strategies

14.3.3.4. SWOT Analysis

14.3.4. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)

14.3.4.1. Company Overview

14.3.4.2. Company Financials

14.3.4.3. Growth Strategies

14.3.4.4. SWOT Analysis

14.3.5. Dr. Reddy?s Laboratories Ltd.

14.3.5.1. Company Overview

14.3.5.2. Company Financials

14.3.5.3. Growth Strategies

14.3.5.4. SWOT Analysis

14.3.6. Cipla, Inc.

14.3.6.1. Company Overview

14.3.6.2. Company Financials

14.3.6.3. Growth Strategies

14.3.6.4. SWOT Analysis

14.3.7. Cadila Pharmaceuticals

14.3.7.1. Company Overview

14.3.7.2. Growth Strategies

14.3.7.3. SWOT Analysis

14.3.8. Grupo Ferrer International, S.A.

14.3.8.1. Company Overview

14.3.8.2. Growth Strategies

14.3.8.3. SWOT Analysis

14.3.9. Gebro Pharma GmbH

14.3.9.1. Company Overview

14.3.9.2. Growth Strategies

14.3.9.3. SWOT Analysis

14.3.10. Gilead Sciences, Inc.

14.3.10.1. Company Overview

14.3.10.2. Company Financials

14.3.10.3. Growth Strategies

14.3.10.4. SWOT Analysis

14.3.11. Takeda Pharmaceutical Company Limited

14.3.11.1. Company Overview

14.3.11.2. Company Financials

14.3.11.3. Growth Strategies

14.3.11.4. SWOT Analysis



List of Figures


List of Figure

Figure 01: Global Polypill Products Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 02: Global Polypill Products Market Value (US$ Mn), by Application, 2018

Figure 03: Global Polypill Products Market Value Share Analysis, by Distribution Channel, 2018

Figure 04: Market Overview

Figure 05: Global Polypill Products Market Value Share, by Application, 2018

Figure 06: Global Polypill Products Market Value Share, by Distribution Channel, 2018

Figure 07: Global Polypill Products Market Value Share, by Region, 2018

Figure 08: Global Polypill Products Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 09: Global Polypill Products Market Value Share Analysis, by Application, 2018 and 2027

Figure 10: Global Polypill Products Market Value (US$ Mn) and Y-o-Y Growth, by Cardiovascular, 2017–2027

Figure 11: Global Polypill Products Market Value (US$ Mn) and Y-o-Y Growth, by Diabetes Mellitus, 2017–2027

Figure 12: Global Polypill Products Market Value (US$ Mn) and Y-o-Y Growth, by Anti-infective, 2017–2027

Figure 13: Global Polypill Products Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2017–2027

Figure 14: Global Polypill Products Market Attractiveness Analysis, by Application, 2019–2027

Figure 15: Global Polypill Products Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 16: Global Polypill Products Market Value (US$ Mn) and Y-o-Y Growth, by Hospital Pharmacies, 2017–2027

Figure 17: Global Polypill Products Market Value (US$ Mn) and Y-o-Y Growth, by Retail Pharmacies, 2017–2027

Figure 18: Global Polypill Products Market Value (US$ Mn) and Y-o-Y Growth, by Online Pharmacies, 2017–2027

Figure 19: Global Polypill Products Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 20: Global Polypill Products Market Value Share Analysis, by Region, 2018 and 2027

Figure 21: Global Polypill Products Market Attractiveness Analysis, by Region, 2019–2027

Figure 22: North America Polypill Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 23: North America Polypill Products Market Value Share Analysis, by Application, 2018 and 2027

Figure 24: North America Polypill Products Market Attractiveness Analysis, by Application, 2019–2027

Figure 25: North America Polypill Products Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 26: North America Polypill Products Market Attractiveness Analysis, by Distribution Channel, 2019 -2027

Figure 27: North America Polypill Products Market Value Share Analysis, by Country, 2018 and 2027

Figure 28: North America Polypill Products Market Attractiveness Analysis, by Country, 2019–2027

Figure 29: Europe Polypill Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 30: Europe Polypill Products Market Value Share Analysis, by Application, 2018 and 2027

Figure 31: Europe Polypill Products Market Attractiveness Analysis, by Application, 2019–2027

Figure 32: Europe Polypill Products Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 33: Europe Polypill Products Market Attractiveness Analysis, by Distribution Channel, 2019 -2027

Figure 34: Europe Polypill Products Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 35: Europe Polypill Products Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 36: Asia Pacific Polypill Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 37: Asia Pacific Polypill Products Market Value Share Analysis, by Application, 2018 and 2027

Figure 38: Asia Pacific Polypill Products Market Attractiveness Analysis, by Application, 2019–2027

Figure 39: Asia Pacific Polypill Products Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 40: Asia Pacific Polypill Products Market Attractiveness Analysis, by Distribution Channel, 2019 -2027

Figure 41: Asia Pacific Polypill Products Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 42: Asia Pacific Polypill Products Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 43: Latin America Polypill Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 44: Latin America Polypill Products Market Value Share Analysis, by Application, 2018 and 2027

Figure 45: Latin America Polypill Products Market Attractiveness Analysis, by Application, 2019–2027

Figure 46: Latin America Polypill Products Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 47: Latin America Polypill Products Market Attractiveness Analysis, by Distribution Channel, 2019 -2027

Figure 48: Latin America Polypill Products Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 49: Latin America Polypill Products Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 50: Middle East & Africa Polypill Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 51: Middle East & Africa Polypill Products Market Value Share Analysis, by Application, 2018 and 2027

Figure 52: Middle East & Africa Polypill Products Market Attractiveness Analysis, by Application, 2019–2027

Figure 53: Middle East & Africa Polypill Products Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 54: Middle East & Africa Polypill Products Market Attractiveness Analysis, by Distribution Channel, 2019 -2027

Figure 55: Middle East & Africa Polypill Products Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 56: Middle East & Africa Polypill Products Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 57: Market Position Analysis, 2018, by Tier and Size of the Company

Figure 58: Pfizer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 59: Pfizer, Inc. Breakdown of Net Sales, by Geography, 2018

Figure 60: Pfizer, Inc. Breakdown of Net Sales, by Business Segments (%), 2018

Figure 61: Pfizer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 62: AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 63: AstraZeneca Breakdown of Net Sales (%), by Geography, 2018

Figure 64: AstraZeneca R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 65: AstraZeneca Respiratory Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 66: Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 67: Merck & Co., Inc. Breakdown of Net Sales (%), by Region/Country, 2018

Figure 68: Merck & Co., Inc. Revenue Breakdown of Net Sales (%), by Segment, 2018

Figure 69: Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 70: Johnson & Johnson Pharmaceutical Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 71: Johnson & Johnson Breakdown of Net Sales (%), of Pharmaceutical Segment by Region/Country, 2018

Figure 72: Johnson & Johnson Revenue Breakdown of Net Sales (%), by Pharmaceutical Segment, 2018

Figure 73: Johnson & Johnson, Pharmaceutical Segment R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 74: Dr. Reddy’s Laboratories Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 75: Dr. Reddy’s Laboratories Ltd. Breakdown of Net Sales (%) of Global Generics Business Segment, by Region/Country, 2018

Figure 76: Dr. Reddy’s Laboratories Ltd. Revenue Breakdown of Net Sales (%), by Global Generics Segment, 2018

Figure 77: Dr. Reddy’s Laboratories Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 78: Cipla Inc., Revenue (US$ Mn), 2017–2018

Figure 79: Cipla Inc., Breakdown of Net Sales (%), by Region, 2018

Figure 80: Cipla Inc., Breakdown of Net Sales (%), by Business Segment, 2018

Figure 81: Gilead Sciences, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 82: Genvoya Breakdown of Net Sales (%), by Region/Country, 2018

Figure 83: Stribild Breakdown of Net Sales (%), by Region/Country, 2018

Figure 84: Gilead Sciences, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2018

Figure 85: Takeda Pharmaceutical Company Limited Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 86: Takeda Pharmaceutical Company Limited Breakdown of Net Sales (%), by Region/Country, 2019

Figure 87: Takeda Pharmaceutical Company Limited R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2019


List of Tables


List of Table

Table 01: Global Polypill Products Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 02: Global Polypill Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 03: Global Polypill Products Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 04: North America Polypill Products Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 05: North America Polypill Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 06: North America Polypill Products Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 07: Europe Polypill Products Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 08: Europe Polypill Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 09: Europe Polypill Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 10: Asia Pacific Polypill Products Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 11: Asia Pacific Polypill Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 12: Asia Pacific Polypill Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 13: Latin America Polypill Products Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 14: Latin America Polypill Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 15: Latin America Polypill Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Middle East & Africa Polypill Products Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 17: Middle East & Africa Polypill Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 18: Middle East & Africa Polypill Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027